Corporate Governance3 Sept 2026, 07:51 pm
Speciality Medicines Ltd Submits FY26 Annual Report
AI Summary
Speciality Medicines Ltd has submitted its Annual Report for the financial year 2025-26, as per Regulation 34(1) of SEBI (Listing Obligations and Disclosures requirements) Regulations, 2015. The report includes details on corporate information, board and director's reports, CSR activities, related party transactions, employee particulars, secretarial audit report, management discussion and analysis, standalone financial statements (Balance Sheet, Profit & Loss, Cash Flow), and the Notice of the Annual General Meeting. The company was formerly known as Speciality Medicines Private Limited and its CIN is L85300GJ2021PLC120022. Key managerial personnel include a CFO and Company Secretary.
Key Highlights
- Company submitted its Annual Report for FY 2025-26.
- Report includes financial statements and corporate governance details.
- Details on CSR, related parties, and employee particulars are provided.
- Secretarial Audit Report for FY 2025-26 is included.
- Notice of Annual General Meeting is part of the submission.
Price Impact
More from SPML